Kelonia Therapeutics has a total of 9 patents globally, out of which no patents have been granted. Of these 9 patents, more than 88% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Kelonia Therapeutics.
Kelonia Therapeutics was founded in the year 2017. The Company is developing a new wave of genetic medicines using its next-generation vivo gene delivery platform.
Do read about some of the most popular patents of Kelonia Therapeutics which have been covered by us in this article and also you can find Kelonia Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Kelonia Therapeutics patent portfolio.
How many patents does Kelonia Therapeutics have?
Kelonia Therapeutics has a total of 9 patents globally. These patents belong to 1 unique patent families. Out of 9 patents, 8 patents are active.
How Many Patents did Kelonia Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Kelonia Therapeutics Applications Filed | Kelonia Therapeutics Patents Granted |
| 2023 | 2 | – |
| 2022 | 7 | – |
How many Kelonia Therapeutics patents are Alive/Dead?
How Many Patents did Kelonia Therapeutics File in Different Countries?
Countries in which Kelonia Therapeutics Filed Patents
| Country | Patents |
| Australia | 1 |
| Brazil | 1 |
| Canada | 1 |
| Europe | 1 |
| India | 1 |
| Israel | 1 |
| Mexico | 1 |
| New Zealand | 1 |
Where are Research Centres of Kelonia Therapeutics Patents Located?
The Research Centre for all the Kelonia Therapeutics patents is the United States of America.
List of Kelonia Therapeutics Patents
| Kelonia Therapeutics Patents | Title |
| EP4298114A1 | Lymphocyte Targeted Lentiviral Vectors |
| IN202317060765A | Lymphocyte Targeted Lentiviral Vectors |
| MX2023009910A | Lentiviral Vectors Directed To Lymphocytes |
| BR112023017213A2 | Lentiviral Vectors Targeting Lymphocytes |
| IL305411A | Lymphocyte Targeted Lentiviral Vectors |
| AU2022227021A1 | Lymphocyte Targeted Lentiviral Vectors |
| NZ803269A | Lymphocyte Targeted Lentiviral Vectors |
| CA3212006A1 | Lymphocyte Targeted Lentiviral Vectors |
| WO2022183072A1 | Lymphocyte Targeted Lentiviral Vectors |
What are Kelonia Therapeutics key innovation segments?
What Technologies are Covered by Kelonia Therapeutics?
The chart below distributes patents filed by Kelonia Therapeutics